Medicine

Blood Test To Detect Alzheimer’s Goes On Sale To Labs

The Associated Press reports: A company has started selling the first blood test to help diagnose Alzheimer’s disease, a leap for the field that could make it much easier for people to learn whether they have dementia. It also raises concern about the accuracy and impact of such life-altering news. Independent experts are leery because key test results have not …

Read More »

Moderna To Seek FDA Approval For Vaccine Today

Forbes reports: Moderna will submit its Covid-19 vaccine for emergency use approval in the U.S. Monday after new trial data showed it to be 94% effective at preventing the disease, findings that are consistent with earlier data from the Phase 3 clinical trial. New findings from the Phase 3 clinical trial, which involved over 30,000 participants, showed the vaccine to …

Read More »

Doctors Worry Vaccine Side Effects May Deter Patients

CNBC reports: Public health officials and drugmakers must be transparent about the side effects people may experience after getting their first shot of a coronavirus vaccine, doctors urged during a meeting Monday with CDC advisor. Dr. Sandra Fryhofer of the AMA noted that both Pfizer’s and Moderna’s vaccines require two doses at varying intervals. She said she worries whether her …

Read More »

Trials Show Oxford Vax Is 70% Effective On Average

CNBC reports: British pharmaceutical giant AstraZeneca on Monday said an interim analysis of clinical trials showed its coronavirus vaccine has an average efficacy of 70% in protecting against the virus. It comes after a string of encouraging vaccine results in recent weeks, following late-stage trial readouts from Pfizer-BioNTech and Moderna. The AstraZeneca vaccine, developed in collaboration with the University of …

Read More »

FDA Approves Antibody Treatment Given To Trump

The New York Times reports: The Food and Drug Administration has granted emergency authorization for the experimental antibody treatment given to President Trump shortly after he was diagnosed with Covid-19, giving doctors another option to treat Covid-19 patients as cases across the country continue to rise. The emergency authorization for Regeneron’s drug is limited in scope: It is for people …

Read More »

TODAY: Pfizer To Seek Vaccine Approval From FDA

CNBC reports: Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases, with health-care workers, the elderly and people with underlying health conditions getting the first inoculations. Essential workers, teachers and people in …

Read More »

UK’s Oxford Vaccine Shows Strong Immune Response

The BBC reports: The Oxford coronavirus vaccine shows a strong immune response in adults in their 60s and 70s, raising hopes that it can protect age groups most at risk from the virus. Researchers say the Lancet phase two findings, based on 560 healthy adult volunteers, are “encouraging”. They are also testing whether the vaccine stops people developing Covid-19 in …

Read More »

Pfizer Says Vax Has No Serious Side Effects, Works In 94% Of Older Adults, Will Seek FDA Approval In Days

The New York Times reports: The drug maker Pfizer said on Wednesday that its coronavirus vaccine was 95 percent effective and had no serious side effects — the first set of complete results from a late-stage vaccine trial as Covid-19 cases skyrocket around the globe. The data showed that the vaccine prevented mild and severe forms of Covid-19, the company …

Read More »

Gallup: Willingness To Get COVID Vax Rose In October

Just in from Gallup Polling: Americans’ willingness to be vaccinated against COVID-19 rebounded a bit in October, as seen in Gallup polling conducted before Pfizer/BioNTech and Moderna made promising announcements about the likely effectiveness of their coronavirus vaccines. Fifty-eight percent of Americans in the latest poll say they would get a COVID-19 vaccine, up from a low of 50% in …

Read More »

Amazon Shakes Up Drugstores With Online Pharmacy

CNBC reports: Amazon is entering the pharmacy business with a new offering called Amazon Pharmacy, allowing customers in the United States to order prescription medications for home delivery, including free delivery for Amazon Prime members. Amazon has been quietly building out its pharmacy offering for several years after ramping up internal discussions in 2017 and acquiring PillPack in 2018. The …

Read More »

FDA Approves Antibody Drug Given To Chris Christie

The New York Times reports: The Food and Drug Administration has granted emergency authorization of a Covid-19 treatment made by the American pharmaceutical company Eli Lilly that was given to Chris Christie, the former New Jersey governor, when he was infected with the coronavirus. The authorization, announced on Monday, applies only to people newly infected with the virus, and the …

Read More »

Pharmacies Report Record Demand For Flu Shots

Reuters reports: Walmart Inc, Walgreens Boots Alliance Inc, CVS Health Corp and Rite Aid Corp have told Reuters demand for flu shots at their U.S. pharmacies is up sharply – in some cases double from last year – as people try to protect themselves from influenza in the midst of a worsening COVID-19 pandemic.The pharmacies are giving millions more flu …

Read More »

Pfizer To Seek COVID Vaccine Approval After Election

Reuters reports: Pfizer expects to provide safety data and file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vaccine until after the Nov. 3 U.S. presidential election. The regulatory filing for the vaccine could come as soon as safety data is available in the third week of …

Read More »

COVID Drug Trial Paused Over Safety Concerns [VIDEO]

CNBC reports: Eli Lilly’s late-stage trial of its leading monoclonal antibody treatment for the coronavirus has been paused by U.S. health regulators over potential safety concerns, the company confirmed to CNBC on Tuesday. “Safety is of the utmost importance to Lilly. We are aware that, out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has …

Read More »

“Unexplained Illness” Pauses J&J COVID Vaccine Trial

Reuters reports: Johnson & Johnson has paused clinical trials of its coronavirus vaccine candidate due to an unexplained illness in a study participant, delaying one of the highest profile efforts to contain the global pandemic. The move comes around a month after AstraZeneca AZN.L also suspended trials of its experimental coronavirus vaccine – which uses a similar technology – due …

Read More »

Discoverers Of Hep C Virus Win Nobel For Medicine

CBS News reports: Americans Harvey J. Alter and Charles M. Rice, and British scientist Michael Houghton were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the Hepatitis C virus. The head of the Nobel Committee, Thomas Perlmann, announced the winners in Stockholm. The medicine prize carried particular significance this year due to the coronavirus …

Read More »

First Person Cured Of HIV Dies Of Cancer At Age 54

The Associated Press reports: Timothy Ray Brown, who made history as “the Berlin patient,” the first person known to be cured of HIV infection, has died. He was 54. Brown died Tuesday at his home in Palm Springs, California, according to a social media post by his partner, Tim Hoeffgen. The cause was a return of the cancer that originally …

Read More »

Study Shows Moderna Vax Effective In Older Adults

Reuters reports: Results from an early safety study of Moderna Inc’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers said on Tuesday. The study, published in the New England Journal of Medicine, offers a more complete …

Read More »

Chinese Pharma Will Seek FDA Approval For Vaccine

The Washington Post reports: A coronavirus vaccine being developed by the Chinese pharmaceutical company SinoVac will be ready for worldwide distribution by early next year, its CEO said Thursday. The vaccine, dubbed CoronaVac, is one of four in China that is still undergoing a third and final round of testing, a global standard necessary before it can be widely distributed. …

Read More »

J&J Begins Final Trial Of Single-Shot COVID Vaccine

Reuters reports: Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of millions of doses compared with leading rivals using two doses. The company expects results of the Phase III trial by year end or early next year, Dr. Paul Stoffels, J&J’s chief scientific officer, said in a …

Read More »